AnaptysBio, Inc.
(ANAB - NASDAQ)
66,59 USD
📋 Profilo Aziendale

AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications.

|